PDL BIOPHARMA, INC. company info

CIK 882104
IRS Number 943023969
State of incorporation DE
Business address 932 SOUTHWOOD BLVD
None
INCLINE VILLAGE
NV
89451
Mail address 932 SOUTHWOOD BLVD
None
INCLINE VILLAGE
NV
89451

Short summary

PDL BIOPHARMA, INC. is a Nevada company, with head office located at 932 Southwood Blvd Incline Village, Nevada 89451. In 2018 the company owned a total of 890.46 million USD worth of assets, including 399.70 million USD worth of current assets. 2016 was the year when the company amassed the most assets.

PDL BIOPHARMA, INC. Income Statement

Name [in Millions USD]200720082009201020112012201320142015201620172018Trends
Revenue, Net 442.92
Research and development 003.827.382.96
Operating Expenses 51.5421.06133.9018.3425.4729.7634.9140.07114.90126.28248.70
Operating Income (Loss) 242.65297.12211.08343.70355.41426.51546.31550.38129.40193.78-50.59
Interest expense 14.2219.3643.5336.1029.0424.8739.2127.0618.2720.2212.16
Income Tax Expense (Benefit) 5.0190.6358.50108.04115.46137.35179.03197.3445.7173.8312.94
Net income 68.39189.6691.87199.39211.67264.53322.24332.8063.61110.75-68.86

PDL BIOPHARMA, INC. Balance Sheet

Name [in Millions USD]200720082009201020112012201320142015201620172018Trends
Cash and cash equivalents 340.63174.43211.31168.02184.51251.47214.53292.07115.85349.43395.65284.94
Accounts Receivable, Net, Current 0.1500.6001.350.402.8840.1231.1821.65
Inventories 011.4514.8016.26
Deferred income taxes 10.445.160.24
Property, Plant and Equipment, Gross 9.149.149.169.199.249.189.2118.6918.20
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment 9.069.129.139.159.189.159.1711.4714.20
Goodwill 03.74
Intangible Assets, Net (Excluding Goodwill) 223.750228.3554.4750.45
Other Assets, Noncurrent 7.728.899.683.308.067.1611.608.4025.6428.67
Total assets 271.53284.26259.83401.42916.41995.541,049.191,301.97946.00890.46
Current assets 241.11212.43236.82283.96230.05367.10320.71536.81508.67399.70
Accounts payable 0.180.120.160.120.340.701.0710.3911.2114.81
Total current liabilities 307.60217.0292.49237.23308.41143.9422.60276.2945.7238.34
Long-term Debt 428.62335.25410.25477.39246.45276.45150150
Deferred income taxes 10.4010.403.423.5413.80
Total liabilities 706.39577.77420.94402.69619.74468.33310.54483.17233.37225.04
Common Stock, Value, Issued 1.201.401.401.401.601.641.661.541.461.16
Retained Earnings (Accumulated Deficit) -257.15-126.8971.65232.83418.75640.02853.54932.52811.40759.08
Accumulated Other Comprehensive Income (Loss), Net of Tax 17.08-6.000.40-1.81-3.104.720000

PDL BIOPHARMA, INC. Cash Flow

Name [in Millions USD]200720082009201020112012201320142015201620172018Trends
Net income 68.39189.6691.87199.39211.67264.53322.24332.8063.61110.75-68.86
Depreciation and amortization 0.990.331.410.95
Amortization of Intangible Assets 1.59005.64001224.6915.80
Depreciation and amortization 1.410.95-0.40-0.130.040.022.373.70
Deferred Income Tax Expense (Benefit) -21.9110.24-5.6824.4711.31-1.00-30.6617.07-9.4339.1213.85
Accounts receivable 12.49-12.45-0.580.13-0.23-0.070034.12-5.88-9.34
Inventories 003.231.128.31
Accounts payable -7.18-1.352.17
Deferred revenue 23.670.11
Net Cash Provided by (Used in) Operating Activities 80.15186.95184.30169.78212.51269.75292.28301.47101.7240.62-13.43
Payments to Acquire Property, Plant, and Equipment 3.270.04000.050.000.050.010.031.304.52
Payments to Acquire Intangible Assets 00241.31
Net Cash Provided by (Used in) Investing Activities 586.8218.43-36.90-24.05-71.71-297.99-138.11-79.65-144.51458.8956.70
Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures 15.391.4000.00000000.06
Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures 15.391.4000.00000000.06
Proceeds from Issuance of Common Stock 15.391.40
Payments for Repurchase of Common Stock 003049.11
Payments of Ordinary Dividends, Common Stock 83.8083.90
Net Cash Provided by (Used in) Financing Activities -878.54-31.22-239.06-188.76-178.13-9.8242.90-294.31-28.94-119.40-175.96
Cash and Cash Equivalents, Period Increase (Decrease) -211.58174.17-91.65-43.03-37.33-36.91197.08-72.49-71.73380.11-132.68